| Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ... Nature communications 11 (1), 4489, 2020 | 153 | 2020 |
| Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors P Winograd, S Hou, CM Court, YT Lee, PJ Chen, Y Zhu, S Sadeghi, ... Hepatology Communications, 2020 | 69 | 2020 |
| The mortality and overall survival trends of primary liver cancer in the United States YT Lee, JJ Wang, M Luu, M Noureddin, K Kosari, VG Agopian, NE Rich, ... JNCI: Journal of the National Cancer Institute 113 (11), 1531-1541, 2021 | 53 | 2021 |
| Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States YT Lee, JJ Wang, M Luu, M Noureddin, NN Nissen, TC Patel, LR Roberts, ... Hepatology 74 (5), 2622-2632, 2021 | 36 | 2021 |
| State‐Level HCC Incidence and Association With Obesity and Physical Activity in the United States YT Lee, JJ Wang, M Luu, HR Tseng, NE Rich, SC Lu, NN Nissen, ... Hepatology 74 (3), 1384-1394, 2021 | 35 | 2021 |
| The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma YT Lee, BV Tran, JJ Wang, IY Liang, S You, Y Zhu, VG Agopian, ... Cancers 13 (12), 3076, 2021 | 33 | 2021 |
| Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders Y Afshar, J Dong, P Zhao, L Li, S Wang, RY Zhang, C Zhang, O Yin, ... Nature communications 12 (1), 4408, 2021 | 30 | 2021 |
| Diagnostic Criteria and LI‐RADS for Hepatocellular Carcinoma YT Lee, JJ Wang, Y Zhu, VG Agopian, HR Tseng, JD Yang Clinical Liver Disease 17 (6), 409-413, 2021 | 28 | 2021 |
| HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma N Sun, C Zhang, YT Lee, BV Tran, J Wang, H Kim, J Lee, RY Zhang, ... Hepatology, 2022 | 25 | 2022 |
| A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer YJ Jan, J Yoon, JF Chen, PC Teng, N Yao, S Cheng, A Lozano, GCY Chu, ... Theranostics 9 (10), 2812, 2019 | 23 | 2019 |
| Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips N Sun, Y Yang, H Miao, P Redublo, H Liu, W Liu, YW Huang, PC Teng, ... Biosensors and Bioelectronics 199, 113854, 2022 | 11 | 2022 |
| Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive … YT Lee, N Sun, M Kim, JJ Wang, BV Tran, RY Zhang, D Qi, C Zhang, ... Liver Transplantation, 2021 | 10 | 2021 |
| Prostate cancer extracellular vesicle digital scoring assay–a rapid noninvasive approach for quantification of disease-relevant mRNAs JJ Wang, N Sun, YT Lee, M Kim, T Vagner, K Rohena-Rivera, Z Wang, ... Nano Today 48, 101746, 2023 | 6 | 2023 |
| Covalent Chemistry‐Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma N Sun, YT Lee, M Kim, JJ Wang, C Zhang, PC Teng, D Qi, RY Zhang, ... Advanced Materials Technologies 6 (5), 2001056, 2021 | 5 | 2021 |
| An extracellular vesicle-based assay for noninvasive detection of metastases and monitoring prostate cancer. JJ Wang, N Sun, YT Lee, M Kim, S You, D Di Vizio, HR Tseng, JF Chen, ... Journal of Clinical Oncology 40 (16_suppl), e17004-e17004, 2022 | 1 | 2022 |
| Extracellular vesicle-based assay for detecting metastases and dynamic monitoring of prostate cancer. JJ Wang, N Sun, YT Lee, M Kim, S You, HR Tseng, Y Zhu, EM Posadas Journal of Clinical Oncology 40 (6_suppl), 182-182, 2022 | 1 | 2022 |
| Nuclear size of circulating tumor cells in advanced prostate cancer to reveal a potential biomarker for clinical outcomes and androgen receptor indifference. JJ Wang, KA Cavassani, PC Teng, JF Chen, YJ Jan, GCY Chu, YT Lee, ... Journal of Clinical Oncology 39 (6_suppl), 167-167, 2021 | 1 | 2021 |
| Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. PC Teng, YJ Jan, M Kim, JF Chen, J Yoon, JJ Wang, PJ Chen, N Yao, ... Journal of Clinical Oncology 38 (15_suppl), e17509-e17509, 2020 | 1 | 2020 |
| Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy. PC Teng, YJ Jan, JF Chen, M Kim, N Yao, I Garraway, GCY Chu, PJ Chen, ... Journal of Clinical Oncology 38 (6_suppl), 170-170, 2020 | 1 | 2020 |
| Luminal and basal subtyping of circulating tumor cells and influence on outcomes in patients with metastatic castration-resistant prostate cancer. JJ Wang, M Kim, PC Teng, YJ Jan, JF Chen, Y Zhu, S You, HR Tseng, ... Journal of Clinical Oncology 41 (16_suppl), e17034-e17034, 2023 | | 2023 |
Hsian-Rong Tseng (曾憲榮)Professor, Department of Molecular and Medical Pharmacology, UCLAVerified email at mednet.ucla.edu
